Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1/2 4Phase 1 4Phase EARLY_PHASE1 1Phase 4 1Phase 3 1

Status

Completed 32Terminated 10Recruiting 6Unknown 4Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 2Gastrointestinal 1CNS 1

Conditions

Advanced Malignant Solid Tumor 2Resectable Pancreatic Cancer 1Glioma 1Glioblastoma 1

Interventions

Cyclophosphamide 51fludarabine 38Injections 32Gemcitabine 25Paclitaxel 24Cisplatin 22Radiotherapy 19toripalimab 18pembrolizumab 18Carboplatin 17Capecitabine 17Fluorouracil 15Oxaliplatin 14Nivolumab 14Docetaxel 12camrelizumab 11apatinib 11Temozolomide 11Immunotherapy, Adoptive 11Cetuximab 11Bevacizumab 10Irinotecan 9Drug Therapy 9sintilimab 8Etoposide 8aldesleukin 7Taxes 7Rituximab 7Radiosurgery 7Peripheral Blood Stem Cell Transplantation 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Unknown × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all
NCT03662815 2021-11-16

Clinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant Tumor

Sir Run Run Shaw Hospital

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT04810910 2021-11-16

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Zhejiang Provincial People's Hospital

Phase 1 Unknown
20 enrolled
Gastrointestinal

Resectable Pancreatic Cancer

NCT04864379 2021-04-28

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Sir Run Run Shaw Hospital

Phase 1 Unknown
30 enrolled
Other solid neoplasm

Advanced Malignant Solid Tumor

NCT03392545 2019-07-11

InSituVac1

Beijing Tiantan Hospital

Phase 1 Unknown
30 enrolled
CNS

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡